Early diagnosis of sepsis utilizing antigen-antibody...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/569 (2006.01) G01N 1/38 (2006.01) G01N 21/76 (2006.01) G01N 33/50 (2006.01) G01N 33/52 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2097952

A method for determining the extent of sepsis in a patient by detecting the presence of antigen indicative of sepsis in a patient blood-derived test sample containing white blood cell fractions, the method comprises: i) incubating the test sample with antibodies specific to the antigens indicative of sepsis to form antibody/antigen complexes, ii) introducing a chemiluminescent compound to the test sample, and iii) allowing the antibody/antigen complexes to interact with the white blood cell fractions to produce oxidants. After the above steps are conducted in any order then: iv) the oxidants reacting with the chemiluminescent compounds cause luminescent light to be emitted from the test sample, and v) the emitted light over a predetermined period is measured and correlated with the extent of sepsis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Early diagnosis of sepsis utilizing antigen-antibody... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Early diagnosis of sepsis utilizing antigen-antibody..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Early diagnosis of sepsis utilizing antigen-antibody... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1640458

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.